May 2, 2017 / 8:16 PM / 5 months ago

BRIEF-Aerie Pharmaceuticals Q1 adjusted loss per share $0.62

May 2 (Reuters) - Aerie Pharmaceuticals Inc:

* Aerie Pharmaceuticals reports first quarter 2017 financial results and provides business update

* Q1 adjusted loss per share $0.62

* Q1 earnings per share view $-0.67 -- Thomson Reuters I/B/E/S

* Q1 gaap loss per share $0.76 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below